文献
J-GLOBAL ID:202002245459925188
整理番号:20A2196896
フィリリン(KD-1)は核因子カッパB(NF-κB)シグナル伝達経路を抑制することにより新規コロナウイルス(SARS-CoV-2)およびヒトコロナウイルス229E(HCoV-229E)に対する抗ウイルスおよび抗炎症活性を発揮する【JST・京大機械翻訳】
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
著者 (19件):
Ma Qinhai
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Li Runfeng
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Pan Weiqi
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Huang Wenbo
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Liu Bin
(Kunming University of Science and Technology Library, Kunming, China)
,
Xie Yuqi
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Wang Zhoulang
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Li Chufang
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Jiang Haiming
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Huang Jicheng
(Technology Centre, Guangzhou Customs, Guangzhou, China)
,
Shi Yongxia
(Technology Centre, Guangzhou Customs, Guangzhou, China)
,
Dai Jun
(Technology Centre, Guangzhou Customs, Guangzhou, China)
,
Zheng Kui
(Technology Centre, Guangzhou Customs, Guangzhou, China)
,
Li Xiaobo
(Technology Centre, Guangzhou Customs, Guangzhou, China)
,
Hui Min
(Jilin Yatai Chinese Medicine Development Institute, Changchun, Jilin, China)
,
Fu Li
(Jilin Yatai Chinese Medicine Development Institute, Changchun, Jilin, China)
,
Yang Zifeng
(State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China)
,
Yang Zifeng
(State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau SAR, China)
,
Yang Zifeng
(KingMed Virology Diagnostic & Translational Center, Guangzhou, China)
資料名:
Phytomedicine
(Phytomedicine)
巻:
78
ページ:
Null
発行年:
2020年
JST資料番号:
W1767A
ISSN:
0944-7113
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)